Kenneth A. Samet, Director at AdaptHealth Corp. (AHCO), bought 23,500 shares at $6.38 ($150K) on 2026-08-06, disclosed to the SEC on 2026-08-10.
Director Kenneth A. Samet purchased $149,930 worth of shares at $6.38, marking the largest insider purchase in the company's history. This move comes as the stock has crashed nearly 54% over the last 90 days, potentially signaling a contrarian bet on a bottoming valuation.
AHCO shares have plummeted 53.69% over the last 90 days to trade at $5.215, sitting just 0.1% above its 52-week low of $5.21 and 61.17% below the 52-week high of $13.43.
1) Next earnings on August 11, 2026, following a Q2 2026 miss where revenue and profitability fell below expectations due to West Coast operational inefficiencies and a $30M supplier price increase. 2) The company is executing a strategic pivot to focus on sleep, respiratory, and home medical equipment following the sale of its diabetes unit. 3) The largest-ever insider purchase by a director suggests a high-conviction bet on the stock's recovery.
1) The stock faces significant headwinds from a negative market reaction to Q2 2026 earnings, with management describing operational challenges as 'not sustainable.' 2) The company is currently trading at a negative forward P/E of -45.39, indicating high expectations for future profitability that could be difficult to meet.
Clearly above the average filing.
| Filing → |
| CGNT | BUY | 2016-11-21 | $124K | — | Filing → |